Number of the records: 1
Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells
- 1.
SYSNO 0510823 Title Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells Author(s) Knox, T. (US)
Sahakian, E. (US)
Banik, D. (US)
Hadley, M. (US)
Palmer, E. (US)
Noonepalle, S. (US)
Kim, J. (US)
Powers, J. (US)
Gracia-Hernandez, M. (US)
Oliveira, V. (US)
Cheng, F. (US)
Chen, J. (US)
Bařinka, Cyril (BTO-N) RID, ORCID
Pinilla-Ibarz, J. (US)
Lee, N. H. (US)
Kozikowski, A. (US)
Villagra, A. (US)Source Title Scientific Reports. Roč. 9, APR 16 2019 (2019). - : Nature Publishing Group Article number 6136 Document Type Článek v odborném periodiku Institutional support BTO-N - RVO:86652036 Language eng Country GB Keywords HISTONE DEACETYLASE 6 * LIGAND 1 EXPRESSION * INFILTRATING LYMPHOCYTES URL https://www.nature.com/articles/s41598-019-42237-3 Permanent Link http://hdl.handle.net/11104/0301209
Number of the records: 1